Fatourechi Vahab, Aniszewski Jaroslaw P, Fatourechi Guiti Z Eghbali, Atkinson Elizabeth J, Jacobsen Steven J
Division of Endocrinology, Diabetes, Metabolism, Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Clin Endocrinol Metab. 2003 May;88(5):2100-5. doi: 10.1210/jc.2002-021799.
Subacute thyroiditis (SAT), or granulomatous thyroiditis, is an inflammatory thyroid condition associated with pain and systemic symptoms. Few community studies are available. We studied the 160 patients with SAT in Olmsted County, Minnesota, seen between January 1, 1960, and December 30, 1997. Subjects were identified through the medical diagnostic index of the Rochester Epidemiology Project. The overall age- and sex-adjusted incidence from 1960 through 1997 was 4.9 cases per 100,000/yr. In the most recent 28-yr period (1970-1997), 94 patients were identified. In this group, pain was the presenting symptom in 96%. SAT recurred in 4% of the patients 6-21 yr after the initial episode. Corticosteroid therapy was given to 36%. Early-onset hypothyroidism occurred both in patients receiving corticosteroid therapy (29%) and in those not receiving corticosteroid therapy (37%). At latest follow-up, significantly more patients who had received corticosteroid therapy had a diagnosis of hypothyroidism than the group without corticosteroid therapy (25% vs. 10%, P < 0.05; overall rate of hypothyroidism, 15%). Early transient hypothyroidism is common in SAT. Permanent hypothyroidism is less common, and only 15% of the patients are receiving T(4) therapy after 28 yr of follow-up. Symptomatic relief is achieved with corticosteroid therapy, but such therapy does not prevent early- and late-onset thyroid dysfunction.
亚急性甲状腺炎(SAT),又称肉芽肿性甲状腺炎,是一种伴有疼痛和全身症状的甲状腺炎症性疾病。社区研究较少。我们对1960年1月1日至1997年12月30日期间在明尼苏达州奥尔姆斯特德县就诊的160例亚急性甲状腺炎患者进行了研究。通过罗切斯特流行病学项目的医学诊断索引确定研究对象。1960年至1997年经年龄和性别调整后的总体发病率为每年每10万人中有4.9例。在最近的28年期间(1970 - 1997年),确定了94例患者。在该组中,96%的患者以疼痛为首发症状。4%的患者在首次发作后6 - 21年复发。36%的患者接受了皮质类固醇治疗。接受皮质类固醇治疗的患者(29%)和未接受皮质类固醇治疗的患者(37%)均出现早期甲状腺功能减退。在最近一次随访时,接受皮质类固醇治疗的患者中诊断为甲状腺功能减退的人数明显多于未接受皮质类固醇治疗的组(25%对10%,P < 0.05;甲状腺功能减退的总体发生率为15%)。早期短暂性甲状腺功能减退在亚急性甲状腺炎中很常见。永久性甲状腺功能减退较少见,随访28年后只有15%的患者接受甲状腺素(T4)治疗。皮质类固醇治疗可缓解症状,但这种治疗不能预防早发性和迟发性甲状腺功能障碍。